ARHGAP11A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.12870054916436E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.28429999862934E-08 |
Normal-vs-Stage2 |
2.31569999999959E-05 |
Normal-vs-Stage3 |
1.11249999990015E-07 |
Normal-vs-Stage4 |
3.70279999994949E-08 |
Stage1-vs-Stage2 |
5.520200E-01 |
Stage1-vs-Stage3 |
1.370200E-01 |
Stage1-vs-Stage4 |
3.421700E-03 |
Stage2-vs-Stage3 |
5.228600E-01 |
Stage2-vs-Stage4 |
2.801900E-02 |
Stage3-vs-Stage4 |
7.320200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.15030248951598E-11 |
Normal-vs-AfricanAmerican |
3.299500E-03 |
Normal-vs-Asian |
1.171390E-01 |
Caucasian-vs-AfricanAmerican |
1.083340E-03 |
Caucasian-vs-Asian |
5.011200E-01 |
AfricanAmerican-vs-Asian |
3.129200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.47309999940649E-11 |
Normal-vs-Female |
1.84060000019137E-07 |
Male-vs-Female |
1.199190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.381900E-04 |
Normal-vs-Age(41-60Yrs) |
1.77899994735498E-09 |
Normal-vs-Age(61-80Yrs) |
1.23440000443509E-08 |
Normal-vs-Age(81-100Yrs) |
1.003300E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.294000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.165400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.482970E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.005800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.759700E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.153670E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.420300E-03 |
Normal-vs-Grade 2 |
2.01770000041179E-07 |
Normal-vs-Grade 3 |
8.53189996430359E-09 |
Normal-vs-Grade 4 |
4.0682000002068E-07 |
Grade 1-vs-Grade 2 |
1.247740E-02 |
Grade 1-vs-Grade 3 |
4.995500E-04 |
Grade 1-vs-Grade 4 |
3.019600E-04 |
Grade 2-vs-Grade 3 |
1.548560E-01 |
Grade 2-vs-Grade 4 |
8.897600E-03 |
Grade 3-vs-Grade 4 |
4.254500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.83569999984346E-07 |
Normal-vs-ccB subtype |
9.58729984290585E-10 |
ccA subtype-vs-ccB subtype |
3.308000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.08479999930233E-09 |
Normal-vs-N1 |
1.963820E-04 |
N0-vs-N1 |
1.638400E-03 |
|
|